S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME

• Anna Maria Frustaci,
• Marco Montillo,
• Davide Rossi,
• Pier Luigi Zinzani,
• Marina Motta,
• Gianluca Gaidano,
• Giulia Quaresmini,
• Lydia Scarfò,
• Daniela Pietrasanta,
• Marta Coscia,
• Marina Deodato,
• Giulia Zamprogna,
• Roberto Cairoli,
• Georg Stüssi,
• Emanuele Zucca,
• Stefano Pileri,
• Thorsten Zenz,
• Alessandra Tedeschi

Affiliations

Anna Maria Frustaci

1 ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, Milano, Italy

Marco Montillo

2 ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, Milano, Italy

Davide Rossi

4 Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland

Pier Luigi Zinzani

7 Institute of Haematology “L. e A. Seràgnoli,” University of Bologna, Bologna, Italy

Marina Motta

8 S.C. Ematologia, ASST Spedali Civili, Brescia, Italy.

Gianluca Gaidano

9 Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy

Giulia Quaresmini

10 Azienda Socio-Sanitaria Territoriale Papa Giovanni XXVIII, Bergamo, Italy

Lydia Scarfò

11 Università Vita-Salute San Raffaele and IRCC Ospedale San Raffaele, Milano, Italy

Daniela Pietrasanta

12 Division of Hematology, Azienda Ospedaliera SS Arrigo e Biagio e Cesare Arrigo, Alessandria, Italy

Marta Coscia

13 University Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy

Marina Deodato

1 ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, Milano, Italy

Giulia Zamprogna

1 ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, Milano, Italy

Roberto Cairoli

1 ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, Milano, Italy

Georg Stüssi

4 Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland

Emanuele Zucca

4 Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland

Stefano Pileri

15 Hematopathology division, IRCCS Istituto Europeo di Oncologia, Milano, Italy

Thorsten Zenz

16 Department of Haematology, University Hospital Zürich and University of Zürich, Zürich, Switzerland

Alessandra Tedeschi

1 ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, Milano, Italy